Show simple item record

dc.contributor.authorChai, Peter R.
dc.contributor.authorFerro, E. G.
dc.contributor.authorKirshenbaum, J. M.
dc.contributor.authorHayes, B. D.
dc.contributor.authorCulbreth, S. E.
dc.contributor.authorBoyer, E. W.
dc.contributor.authorErickson, T. B.
dc.date.accessioned2020-10-16T20:05:43Z
dc.date.available2020-10-16T20:05:43Z
dc.date.issued2020-06
dc.date.submitted2020-05
dc.identifier.issn1556-9039
dc.identifier.issn1937-6995
dc.identifier.urihttps://hdl.handle.net/1721.1/128026
dc.description.abstractAbstract Introduction Recent attention on the possible use of hydroxychloroquine and chloroquine to treat COVID-19 disease has potentially triggered a number of overdoses from hydroxychloroquine. Toxicity from hydroxychloroquine manifests with cardiac conduction abnormalities, seizure activity, and muscle weakness. Recognizing this toxidrome and unique management of this toxicity is important in the COVID-19 pandemic. Case Report A 27-year-old man with a history of rheumatoid arthritis presented to the emergency department 7 hours after an intentional overdose of hydroxychloroquine. Initial presentation demonstrated proximal muscle weakness. The patient was found to have a QRS complex of 134 ms and QTc of 710 ms. He was treated with early orotracheal intubation and intravenous diazepam boluses. Due to difficulties formulating continuous diazepam infusions, we opted to utilize an intermitted intravenous bolus strategy that achieved similar effects that a continuous infusion would. The patient recovered without residual side effects. Discussion Hydroxychloroquine toxicity is rare but projected to increase in frequency given its selection as a potential modality to treat COVID-19 disease. It is important for clinicians to recognize the unique effects of hydroxychloroquine poisoning and initiate appropriate emergency maneuvers to improve the outcomes in these patients.en_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttps://doi.org/10.1007/s13181-020-00790-8en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceSpringer USen_US
dc.titleIntentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemicen_US
dc.typeArticleen_US
dc.identifier.citationChai, Peter R. et al. "Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic." Journal of Medical Toxicology 16, 3 (June 2020): 314–320 © 2020 Springer Natureen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.relation.journalJournal of Medical Toxicologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-09-24T21:46:58Z
dc.language.rfc3066en
dc.rights.holderAmerican College of Medical Toxicology
dspace.embargo.termsY
dspace.date.submission2020-09-24T21:46:58Z
mit.journal.volume16en_US
mit.journal.issue3en_US
mit.licensePUBLISHER_POLICY
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record